Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,338Revenue (TTM) $M110Net Margin (%)11.9Altman Z-Score8.1
Enterprise Value $M1,292EPS (TTM) $0.4Operating Margin %16.5Piotroski F-Score5
P/E(ttm)106Beneish M-Score-2.7Pre-tax Margin (%)12.0Higher ROA y-yY
Price/Book7.610-y EBITDA Growth Rate %--Quick Ratio11.8Cash flow > EarningsN
Price/Sales12.25-y EBITDA Growth Rate %40.6Current Ratio13.5Lower Leverage y-yN
Price/Free Cash Flow183y-y EBITDA Growth Rate %45.6ROA % (ttm)5.1Higher Current Ratio y-yY
Dividend Yield %--PEG2.6ROE % (ttm)8.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M34.1ROIC % (ttm)21.1Gross Margin Increase y-yN

Gurus Latest Trades with RGEN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

RGEN is held by these investors:



RGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DAWES KAREN ADirector 2017-03-21Sell2,521$34.1215.06view
Benjamin HowardVP Business Development 2017-03-20Sell12,216$34.6213.4view
RYAN THOMAS F JRDirector 2017-03-20Sell4,000$34.8312.72view
Snodgres JonCFO 2017-03-17Sell1,909$34.9112.46view
Hunt AnthonyCEO 2016-11-28Sell5,000$33.1218.54view
RYAN THOMAS F JRDirector 2016-09-14Sell2,700$32.5820.5view
RYAN THOMAS F JRDirector 2016-06-30Sell5,000$26.647.59view
RYAN THOMAS F JRDirector 2016-06-28Sell10,000$24.5959.66view
Benjamin HowardVP Business Development 2016-05-11Sell2,889$26.7246.93view
Benjamin HowardVP Business Development 2015-06-09Sell35,000$38.142.94view

Quarterly/Annual Reports about RGEN:

News about RGEN:

Articles On GuruFocus.com
Repligen to Participate in 14th Annual Craig-Hallum Institutional Investor Conference May 24 2017 
Repligen to Present at Bank of America Merrill Lynch 2017 Healthcare Conference May 09 2017 
Repligen to Report First Quarter 2017 Financial Results Apr 21 2017 
Repligen Corp. Reports Operating Results (10-Q) Feb 09 2011 
Repligen Corp. Reports Operating Results (10-Q) Nov 02 2010 
Repligen Corp. Reports Operating Results (10-Q) Aug 05 2010 
Repligen Corp. Reports Operating Results (10-Q) Feb 04 2010 
Repligen Corp. Reports Operating Results (10-Q) Nov 05 2009 
Repligen Corp. Reports Operating Results (10-Q) Feb 06 2009 

More From Other Websites
Repligen to Participate in 14th Annual Craig-Hallum Institutional Investor Conference May 24 2017
Top 3 Healthcare Penny Stocks for 2017 May 19 2017
Edited Transcript of RGEN earnings conference call or presentation 4-May-17 12:30pm GMT May 10 2017
Repligen to Present at Bank of America Merrill Lynch 2017 Healthcare Conference May 09 2017
Repligen tops Street 1Q forecasts May 04 2017
Repligen Reports First Quarter 2017 Financial Results May 04 2017
Investor Network: Repligen Corporation to Host Earnings Call May 04 2017
ETFs with exposure to Repligen Corp. : May 1, 2017 May 01 2017
Repligen to Report First Quarter 2017 Financial Results Apr 21 2017
ETFs with exposure to Repligen Corp. : April 7, 2017 Apr 07 2017
Stocks Flat But Alphabet, Lockheed Martin Hit New Highs Mar 17 2017
Repligen Corp. :RGEN-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017 Feb 23 2017
Edited Transcript of RGEN earnings conference call or presentation 22-Feb-17 1:30pm GMT Feb 22 2017
Repligen beats 4Q profit forecasts Feb 22 2017
Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : February 21, 2017 Feb 21 2017
The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin... Jan 04 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)